Custom Assays

At T Cell Diagnostics, we offer a comprehensive suite of customisable immunological assays designed to assess T cell function, phenotype, and antigen specificity.
Our flexible platforms cater to diverse research and clinical needs, offering high-resolution insights into immune responses across various viral infections, vaccine trials, and immunotherapy programs.
ELISpot assays provide a highly sensitive measurement of cytokine secretion (e.g., IFN-γ, IL-2) at the single-cell level following antigen-specific stimulation. This method quantifies the frequency of reactive T cells and is ideal for monitoring vaccine responses or infection-driven immunity.
ICS involves stimulating T cells with specific antigens, followed by fixation, permeabilisation, and staining for intracellular cytokines. Using flow cytometry, this assay enables detailed functional and phenotypic profiling of T cell subsets, including CD4⁺ and CD8⁺ populations.
MHC tetramers loaded with defined viral peptides bind selectively to antigen-specific T cell receptors (TCRs). This technique enables the direct identification and quantification of antigen-specific T cells using flow cytometry, providing unparalleled specificity and precision.
AIM assays detect the surface expression of activation markers, such as CD69, CD137, and OX40, following antigen stimulation. Unlike cytokine-based assays, AIM provides a cytokine-independent readout of T cell activation, suitable for assessing rare or functionally diverse T cell populations.
These assays assess the functional capacity of cytotoxic T lymphocytes (CTLs) to eliminate target cells that present specific viral antigens. By measuring cell lysis or apoptosis, cytotoxicity assays provide crucial insights into the antiviral function of T cell effector cells.
Our proprietary CRA simplifies T cell testing by using fresh whole blood and eliminating the need for PBMC isolation. After stimulation with peptide pools, cytokine release (e.g., IFN-γ, IL-2, Granzyme B, IL-4, IL-5, IL-10, IL-17) is measured directly from plasma, enabling rapid, scalable, and clinically relevant immune monitoring.
Customization Options
Pathogen-specific peptide pools
e.g., HBV, SARS-CoV-2, Dengue, HCMV
Sample types supported
Whole blood, PBMCs, tissue-derived cells
Assay readouts
Flow cytometry, ELISA, Luminex, FluoroSpot
Endpoint flexibility
Cytokine secretion, activation markers, cell proliferation, cytotoxicity